These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2845994)

  • 1. Comparison of cyclic nucleotide phosphodiesterase isoforms from rat heart and bovine aorta. Separation and inhibition by selective reference phosphodiesterase inhibitors.
    Prigent AF; Fougier S; Nemoz G; Anker G; Pacheco H; Lugnier C; Lebec A; Stoclet JC
    Biochem Pharmacol; 1988 Oct; 37(19):3671-81. PubMed ID: 2845994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
    Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta.
    Ahn HS; Crim W; Romano M; Sybertz E; Pitts B
    Biochem Pharmacol; 1989 Oct; 38(19):3331-9. PubMed ID: 2554921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue.
    Bode DC; Kanter JR; Brunton LL
    Circ Res; 1991 Apr; 68(4):1070-9. PubMed ID: 1849058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents.
    Weishaar RE; Burrows SD; Kobylarz DC; Quade MM; Evans DB
    Biochem Pharmacol; 1986 Mar; 35(5):787-800. PubMed ID: 3006691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and selective inhibition of four distinct soluble forms of cyclic nucleotide phosphodiesterase activity from kidney.
    Hoey M; Houslay MD
    Biochem Pharmacol; 1990 Jul; 40(2):193-202. PubMed ID: 2165400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of multiple forms of cyclic nucleotide phosphodiesterase from hog heart.
    Nasu S
    Bull Osaka Med Sch; 1976 Oct; 22(2):51-68. PubMed ID: 203355
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
    Barnette MS; Manning CD; Price WJ; Barone FC
    J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells.
    Tani T; Sakurai K; Kimura Y; Ishikawa T; Hidaka H
    Adv Second Messenger Phosphoprotein Res; 1992; 25():215-27. PubMed ID: 1372812
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphodiesterases in vascular endothelial cells.
    Kishi Y; Ashikaga T; Numano F
    Adv Second Messenger Phosphoprotein Res; 1992; 25():201-13. PubMed ID: 1372811
    [No Abstract]   [Full Text] [Related]  

  • 13. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.
    Reeves ML; Leigh BK; England PJ
    Biochem J; 1987 Jan; 241(2):535-41. PubMed ID: 3036066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of NZ-105, a 1,4-dihydropyridine derivative, on cyclic nucleotide phosphodiesterase activity.
    Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
    J Pharm Pharmacol; 1993 Jun; 45(6):530-4. PubMed ID: 7689649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta.
    Saeki T; Saito I
    Biochem Pharmacol; 1993 Sep; 46(5):833-9. PubMed ID: 8396936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoelectric-focusing patterns of cyclic nucleotide phosphodiesterase from rat heart.
    Némoz G; Prigent AF; Pageaux JF; Pacheco H
    Biochem J; 1981 Oct; 199(1):113-9. PubMed ID: 6279093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Purification of cyclic nucleotide phosphodiesterase from the external segments of retinal rods; conjugation of the enzyme with an inhibitor].
    Furaev VV; Dumler IL; Kazimirskiĭ AN; Etingof RN
    Dokl Akad Nauk SSSR; 1978; 243(1):247-50. PubMed ID: 214282
    [No Abstract]   [Full Text] [Related]  

  • 18. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
    Drees M; Zimmermann R; Eisenbrand G
    Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors.
    Shahid M; van Amsterdam RG; de Boer J; ten Berge RE; Nicholson CD; Zaagsma J
    Br J Pharmacol; 1991 Oct; 104(2):471-7. PubMed ID: 1665737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.